New drug aims to calm heart arteries after attack
NCT ID NCT07276282
Summary
This study is testing whether a new drug called ziltivekimab can help stabilize the fatty plaques in heart arteries after a heart attack. About 332 participants who recently had a heart attack will be randomly assigned to receive either the new drug or a placebo injection once a month, in addition to their standard care. Doctors will use special imaging to look inside the heart arteries over 15 months to see if the drug reduces dangerous plaque buildup and makes plaques less likely to rupture.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bern University Hospital, Inselspital Bern
Bern, Switzerland
Contact
Conditions
Explore the condition pages connected to this study.